EMEA-000249-PIP01-10

Key facts

Invented name
Fluenz
Active substance
Influenza Virus Type A, H3N2Influenza Virus Type A, H1N1Influenza Virus Type B
Therapeutic area
Vaccines
Decision number
P/14/2011
PIP number
EMEA-000249-PIP01-10
Pharmaceutical form(s)
Nasal spray suspension
Condition(s) / indication(s)
Prevention of influenza infection
Route(s) of administration
Intranasal
Contact for public enquiries
MedImmune, LLC
dekkere@medimmune.com
United States
Phone: +1 3013984040
Fax: +1 3013984015
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating